Ongoing studies in animal models have linked glioma angiogenesis and Treg involvement; combining VEGF and CD25 blockades restores the IFN-γ production by T cells previously suppressed by gliomas and significantly prolongs the OS in mice compared with single drug treatment (Long et al., manuscript in preparation). The gene discussed is VEGFA; the disease is glioma.